ECRG2, a novel transcriptional target of p53, modulates cancer cell sensitivity to DNA damage

Harsh Patel(SUNY Upstate Medical University), Ying Huang(SUNY Upstate Medical University)
Cell Death and Disease
July 17, 2020
Cited by 9


Related Papers